SillaJen, Inc.
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
215600 | KO
Overview
Corporate Details
- ISIN(s):
- KR7215600008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 청계천로 106 3층(수표동, 크리스탈스퀘어), 중구
- Website:
- https://www.sillajen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SillaJen, Inc. is a biotechnology company focused on the research, development, and commercialization of oncolytic immunotherapeutics for cancer treatment. The company engineers oncolytic viruses designed to selectively replicate in and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its main pipeline candidate is Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus that has been investigated for the treatment of various solid tumors. SillaJen is dedicated to developing innovative therapeutic options for patients with difficult-to-treat cancers through its proprietary viral engineering platforms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 B…
|
Korean | 28.0 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.9 MB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-08-05 00:00 |
Regulatory News Service
불성실공시법인지정 (공시변경)
|
Korean | 6.1 KB | ||
| 2025-07-15 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인신청) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로…
|
Korean | 26.9 KB | ||
| 2025-07-11 00:00 |
Regulatory News Service
불성실공시법인지정예고 (공시변경)
|
Korean | 5.0 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-01 00:00 |
M&A Activity
합병등종료보고서(합병)
|
Korean | 16.7 KB | ||
| 2025-06-23 00:00 |
M&A Activity
합병등종료보고서(자산양수도)
|
Korean | 16.5 KB | ||
| 2025-06-19 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인신청) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로…
|
Korean | 26.2 KB | ||
| 2025-06-13 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 B…
|
Korean | 25.5 KB | ||
| 2025-05-29 00:00 |
Post-Annual General Meeting Information
기타경영사항(자율공시) (소규모 합병 승인 이사회 결의(주주총회 갈음) 결과 보고)
|
Korean | 8.0 KB | ||
| 2025-05-29 00:00 |
M&A Activity
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
|
Korean | 40.6 KB | ||
| 2025-05-29 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 57.3 KB | ||
| 2025-05-29 00:00 |
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
|
Korean | 31.3 KB |
Automate Your Workflow. Get a real-time feed of all SillaJen, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SillaJen, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SillaJen, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}